Under the aegis of the Fondation de France, Stallergenes Foundation has been launched with the objective appears to improve the management of allergies and make them better known diseases as full by the entire society.
Ranked fourth in the world of chronic disease by the World Health Organization, allergies affect between 10 and 40 % of the world population.
More worryingly, many allergists believe that by 2020, 1 in 2 will be allergic.
In France, more than one in four of respiratory allergies, like all allergies, degrade the quality of life of patients and affect their professional or social, family, school / physical activity is reached.
However, Cyril Tavier, President of the Foundation Stallergenes, ” Allergies are insufficiently recognized as diseases in their own right and our Foundation aims to change perceptions and status of allergies in health system. ” Extending actions since 2007.
To contribute to the prevention and early treatment of allergies, Stallergenes laboratory created in 2007 watching the French Committee allergies.
Its mission was to analyze the economic and social impact of respiratory allergic diseases on the French population and to raise general awareness of the importance of these diseases.
Stallergenes Foundation replaces the CFOA in order to extend and consolidate shares to the general public, health professionals and researchers.
In practice, the Foundation has as mission to observe, train and inform health professionals, educate the public on all forms of allergies and support research by awarding grants to relevant projects, whether in basic, clinical, environmental or societal.
Source : Press release of Stallergenes Foundation December 6, 2013..